IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Cardiology

• Publication date

  2013-10-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2013.04.181PMID 23680589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.

  2011cited by this paper
• Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.

  2010cited by this paper
• Ferric carboxymaltose in patients with heart failure and iron deficiency.

  2009cited by this paper
• Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED‐HF): a Phase III, anaemia correction, morbidity–mortality trial

  2009cited by this paper
• Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.

  2008cited by this paper
• Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.

  2007cited by this paper
• Anemia in Chronic Heart Failure: Prevalence, Etiology, Clinical Correlates, and Treatment Options

  2006cited by this paper
• Regulation of iron metabolism by hepcidin.

  2006cited by this paper
• Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study

  2005cited by this paper
• A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD.

  2005cited by this paper
• Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.

  2004cited by this paper
• Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.

  2003cited by this paper
• Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

  2002cited by this paper
• Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure.

  2002cited by this paper
• The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

  2001cited by this paper
• The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

  2000cited by this paper
• Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles.

  1994cited by this paper
• Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis.

  1994cited by this paper

• From Iron Deficiency to Overload: A Missing Link in the Mechanisms of Cardiac Autonomic Nervous System Dysfunction

  2026cites this paper
• Defining the Role of Intravenous Iron in The Treatment of Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency.

  2026cites this paper
• Impact of Oral Iron on Transferrin Saturation in Iron-deficient HFrEF: A secondary analysis of IRONOUT-HF.

  2025cites this paper
• Practical Anemia Bundle and Hemoglobin Recovery in Critical Illness

  2025cites this paper
• Cardiac Cachexia: A Comprehensive Review.

  2025cites this paper
• Impact of Intravenous Iron Replacement Therapy on Healthcare Costs for Patients with Iron Deficiency Anemia in the USA: A Retrospective Analysis

  2025cites this paper
• Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on hemoglobin, B-type natriuretic peptide, and renal function in anemic heart failure patients: A systematic review and meta-analysis

  2025cites this paper
• Intravenous Ferric Carboxymaltose for Iron Deficiency in Heart Failure Patients: A Meta-Analysis with Trial Sequential Analysis.

  2025cites this paper
• Association of postoperative haemoglobin with adverse outcomes in patients undergoing cardiac surgery: a retrospective single centre cohort study

  2025cites this paper
• Effect of Iron Deficiency on Right Ventricular Strain in Patients Diagnosed with Acute Heart Failure

  2025cites this paper
• Current Research Progress of Iron Deficiency in Heart Failure

  2025cites this paper
• Changes in Cardiac Function and Exercise Capacity Following Ferric Carboxymaltose Administration in HFrEF Patients with Iron Deficiency

  2025cites this paper
• Iron Metabolism in Cardiovascular Disease.

  2025cites this paper
• The association between iron deficiency and muscle mass/strength in patients undergoing maintenance hemodialysis

  2025cites this paper
• Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials

  2024influential citation
• Prognostic Value of Repeated Peak Oxygen Uptake Measurements in LVAD Patients.

  2024cites this paper
• Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence

  2024cites this paper
• Iron supplementation is a residual piece of management in Asian patients with heart failure?

  2024cites this paper
• Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.

  2024cites this paper
• Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions

  2024cites this paper
• Iron deficiency and supplementation in heart failure

  2024cites this paper
• Translating evidence into practice: Managing electrolyte imbalances and iron deficiency in heart failure.

  2024cites this paper
• Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis

  2024cites this paper
• Anemia amongst patients with heart failure - a review

  2024cites this paper
• Efficacy of Intravenous Iron in Patients with Heart Failure with Reduced Ejection Fraction and Iron Deficiency: A Systematic Review and Meta-Analysis of Randomized Control Trials

  2024influential citation
• Iron Deficiency, Anemia, and Iron Supplementation in Patients With Heart Failure: A Population-Level Study

  2024cites this paper
• Intravenous Iron Repletion for Patients With Heart Failure and Iron Deficiency: JACC State-of-the-Art Review.

  2024cites this paper
• Identification of three mechanistic pathways for iron-deficient heart failure

  2024cites this paper
• Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis

  2024cites this paper
• Iron and cardiovascular health: A review

  2024cites this paper
• Anemia and heart failure

  2024cites this paper
• Advances in management of heart failure

  2024cites this paper
• Construction and validation of nomogram prediction model for risk of acute heart failure in patients with acute exacerbation of chronic obstructive pulmonary disease

  2024cites this paper
• Intravenous Iron Therapy in Heart Failure Patients With Iron Deficiency: Benefits, Safety, and Guidelines.

  2024cites this paper
• Ferric Carboxymaltose in Patients with Acute Decompensated Heart Failure and Iron Deficiency: A Real-Life Study

  2023cites this paper
• Intravenous iron therapy for iron deficiency in patients with heart failure: An updated systematic review and meta-analysis

  2023cites this paper
• Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx)

  2023cites this paper
• Benefits of intravenous iron supplementation in patients with heart failure: mounting evidence and open questions

  2023cites this paper
• Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx)

  2023cites this paper
• Importance of anemia in heart failure over blood pressure variability

  2023cites this paper
• An overview of iron deficiency anaemia and its management options

  2023cites this paper
• Meta-Analysis of Efficacy and Safety of Intravenous Iron in Patients With Iron Deficiency and Heart Failure With Reduced Ejection Fraction.

  2023cites this paper
• Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy

  2023cites this paper
• Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials

  2023cites this paper
• Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets

  2023cites this paper
• Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial

  2023cites this paper
• TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.

  2023cites this paper
• Effects of Intravenous Iron Replacement Therapy on Cardiovascular Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis

  2023cites this paper
• Association of iron status with all-cause and cause-specific mortality in individuals with diabetes.

  2023cites this paper
• Intravenous Iron for Heart Failure: Updated Systematic Review and Meta-Analysis

  2023cites this paper
• The Beneficial Effect of Intravenous Iron Administration for Chronic Heart Failure: An Updated Meta-analysis and Systematic Review

  2023cites this paper
• Treatment of Iron Deficiency in Heart Failure

  2023cites this paper
• Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review

  2023cites this paper
• Iron Deficiency in Heart Failure: A Korea-Oriented Review

  2023cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach.

  2022cites this paper
• Iron Deficiency in Heart Failure: What Do We Know So Far?

  2022cites this paper
• Cost-effective heart failure management: Meta-analysis of IV iron therapy in iron-deficient heart failure patients

  2022influential citation
• Can Iron Play a Crucial Role in Maintaining Cardiovascular Health in the 21st Century?

  2022cites this paper
• CME Zertifizierte Fortbildung Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz (Teil 2)

  2022cites this paper
• Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: a network meta-analysis of randomized controlled trials.

  2022cites this paper
• Anemia and Heart Failure: A Narrative Review

  2022cites this paper
• Systematic review and meta‐analysis of intravenous iron therapy for adults with non‐anaemic iron deficiency: An abridged Cochrane review

  2022cites this paper
• Management of Iron Deficiency in Heart Failure: A Review of Evidence

  2022influential citation
• Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to action

  2022cites this paper
• Heart Failure

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2022cites this paper
• [Management of iron deficiency in chronic heart failure].

  2022cites this paper
• Micronutrient deficiencies in heart failure: Mitochondrial dysfunction as a common pathophysiological mechanism?

  2022cites this paper
• Erhalt von Leistungsfähigkeit und Lebensqualität bei chronischer Herzinsuffizienz

  2022cites this paper
• Chronic Heart Failure: Clinical Implications of Iron Homeostasis Disturbances Revisited

  2022cites this paper
• Hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in heart failure patients: A protocol for systematic review and meta-analysis

  2022cites this paper
• Iron homeostasis in the heart: Molecular mechanisms and pharmacological implications.

  2022cites this paper
• Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis

  2022cites this paper
• Criteria for Iron Deficiency in Patients With Heart Failure.

  2022influential citation
• Iron deficiency in heart failure: diagnosis and clinical implications

  2022cites this paper
• IV Sodium Ferric Gluconate Complex in Patients Hospitalized Due to Acute Decompensated Heart Failure and Iron Deficiency

  2022cites this paper
• Deficiência de Ferro na Insuficiência Cardíaca com Fração de Ejeção Reduzida: Fisiopatologia, Diagnóstico e Tratamento

  2022cites this paper
• Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia

  2022cites this paper
• Effect of iron supplementation in patients with heart failure and iron deficiency: A systematic review and meta-analysis

  2021cites this paper
• Risk of Infection Associated With Administration of Intravenous Iron

  2021cites this paper
• Iron therapy in iron-deficiency patients with heart failure with preserved ejection fraction

  2021cites this paper
• Relevance of nutritional assessment and treatment to counteract cardiac cachexia and sarcopenia in chronic heart failure.

  2021cites this paper
• Improved and new-onset anemia during follow-up in patients with acute decompensated heart failure

  2021cites this paper
• Prevalence and temporal trends of anemia in patients with heart failure.

  2021cites this paper
• Intravenous Iron Decreases Rehospitalizations but Does not Change mortality in Patients Admitted with Acute Heart Failure and Iron Deficiency: A Systematic review and Meta-analysis

  2021cites this paper
• Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency

  2021cites this paper
• Intravenous iron in heart failure and chronic kidney disease.

  2021cites this paper
• Oral sucrosomial iron in heart failure with a reduced ejection fraction

  2021cites this paper
• Iron replacement therapy in the management of anaemia in non-dialysis chronic renal failure patients: Perspective of the Spanish Nephrology Society Anaemia Group.

  2021cites this paper
• Atualização de Tópicos Emergentes da Diretriz Brasileira de Insuficiência Cardíaca – 2021

  2021cites this paper
• Prevalence and association of iron deficiency with anemia among patients with heart failure in the USA: NHANES 2017-2018

  2021cites this paper
• Dysregulation of Iron Metabolism in Cardiovascular Diseases: from Iron Deficiency to Iron Overload.

  2021cites this paper
• Consensus of experts from the French Society of Geriatrics and Gerontology on the management of heart failure in very old subjects.

  2021cites this paper
• Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

  2021cites this paper
• Pre-operative Intravenous Iron to Optimise Patients Before Cardiac Surgery

  2021cites this paper
• Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group.

  2021cites this paper